Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 14 Feb 2007 |
| Genmab, preliminary announcement of annual report | 13 Feb 2007 |
| Genmab, Announces Year End 2006 Financial Results | 13 Feb 2007 |
| Genmab, notification from major shareholder (section 29) from GlaxoSmithKline | 9 Feb 2007 |
| Genmab, articles of association dated February 6, 2007. | 8 Feb 2007 |